Sino Biopharmaceutical Limited (stock code 01177) disclosed its monthly return for the period ended 31 October 2025, showing that the authorized share capital remains at 30,000,000,000 ordinary shares with a par value of HKD 0.025 each, for a total of HKD 750,000,000. No changes were recorded during the reporting period.

The total issued shares also remained at 18,760,717,230, with no treasury shares as of the end of October. The report further indicates that there were no movements in share option schemes, warrants, convertibles, or any other arrangements to issue additional shares during the month.